[1]
Hutajulu, S.H. et al. 2024. Clinicopathological Factors and Interleukin-6 Levels Associated With Low Relative Dose Intensity in Women With Breast Cancer Receiving First-Line Chemotherapy. World Journal of Oncology. 15, 6 (Dec. 2024), 942–949. DOI:https://doi.org/10.14740/wjon1954.